Invagesic Forte

   
Google
 
Web NewDrugInformation.com

Invagesic Forte


Drug - Invagesic Forte
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Aspirin; Caffeine; Orphenadrine Citrate
Multiple ingredients are in alphabetical order.

Strength - 770MG;60MG;50MG
The potency of the active ingredient(s), Aspirin; Caffeine; Orphenadrine Citrate. May repeat for multiple part products.

Applicant - SANDOZ
The firm name holding legal responsibility for Invagesic Forte. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 074817
The FDA assigned number to Invagesic Forte. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Invagesic Forte. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Nov 27, 1996
The date Invagesic Forte was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Invagesic Forte. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Invagesic Forte is in. Format is RX, OTC, DISCN.

Applicant Full Name - Sandoz Inc
The full name of the firm holding legal responsibility for the new application of Invagesic Forte.

Invagesic Forte